Viktoria Stuhler
Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Nectin-4 expression in clear cell renal cell carcinoma.
Journal: Scientific reports
Published: March 26, 2026
Priapism: current status and new insights
Journal: Urologie (Heidelberg, Germany)
Published: September 30, 2025
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC.
Journal: Pharmacological research
Published: September 23, 2025
Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomy.
Journal: Journal of cancer research and clinical oncology
Published: July 10, 2025
Penile fracture and concomitant severe urethral trauma-a case report and discussion of surgical approach.
Journal: The Canadian journal of urology
Published: June 01, 2025
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy.
Journal: Cancers
Published: February 13, 2024
Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options.
Journal: Urologia internationalis
Published: September 19, 2023
Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma.
Journal: World journal of urology
Published: June 17, 2023
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases.
Journal: International journal of molecular sciences
Published: December 01, 2022
Real world data on IO-based therapy for metastatic renal cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: June 11, 2022
Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab.
Journal: Cancers
Published: April 26, 2022
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies.
Journal: World journal of urology
Published: November 06, 2021
Last Updated: 09/26/2026